Skip to content
GLP-1 Scorecard
Menu
Graded #247

SkinnyRx

Prints its whole term ladder before intake and then headlines the cheapest rung of it: the advertised $199 is a twelve-month plan charged as one $2,388 payment, and month-to-month is $349.

Visit SkinnyRxWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
Tirzepatide
$399/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
Coverage
47 states + DC (not Alabama, Louisiana or Mississippi)
Brand-name
Compounded only

Weigh SkinnyRx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because SkinnyRx dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value52/100
Dose & formulation88/100
Clinical oversight55/100
Labs & monitoring40/100
Fulfillment82/100
Contract terms38/100

Strengths

  • Both molecules by both routes: semaglutide and tirzepatide as injections, tirzepatide as a tablet on the identical term ladder, plus a separate low-dose line with its own page
  • The full term ladder — every rung, both molecules — is on the product page before any medical intake, which is more than most of this board discloses after one
  • Terms are concrete rather than gestural: free shipping, unlimited provider messaging, a 90-day money-back guarantee, and no charge at all if a clinician finds you ineligible
  • The state exclusions are published rather than discovered at checkout — 47 states plus DC, with Alabama, Louisiana and Mississippi named

Where it loses points

  • FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database
  • The advertised "$199/mo" and "$299/mo" are twelve-month rates by construction — the site's own price code drops the one-month rung before picking a headline — so the monthly rates are $349 semaglutide and $399 tirzepatide
  • Those rungs are a single up-front charge, not a smaller bill: $2,388 for the semaglutide year and $3,588 for the tirzepatide year, taken on day one and auto-renewing each term, with membership fees stated as non-refundable
  • The microdose line costs the SAME as full dose at every term the two share, and its floor is HIGHER — $229 against $199 on semaglutide, $319 against $299 on tirzepatide — because the low-dose plans stop at eight months rather than twelve
  • No brand-name product is actually purchasable: Ozempic, Wegovy, Mounjaro and Zepbound all carry a null price, both pill products are out of stock, and the only priced brand path is a $49/mo membership plus a medication cost that is never published
  • Compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of the brand drugs
  • Fulfillment is disclosed only as a category: "503A pharmacies", never a facility, never a city, and no medical director is named for the programme anywhere on the site — so the two things that decide whether a compounded vial is trustworthy are the two things this seller does not publish
  • Labs and monitoring are simply absent from the site: nothing states whether baseline or follow-up bloodwork is required, included in the membership, or billed on top of it
  • Alabama, Louisiana and Mississippi are excluded, so three states' readers cannot buy at any price on this ladder

Bottom line — Grade C

Best for: Readers who want tirzepatide as a tablet at the same price as the injection and can pay a year up front — anyone comparing monthly costs should grade this row at $349 and $399.

Ranked #247 of 508 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Closest on the board

The boards grading nearest SkinnyRx — the realistic shortlist.

The 24 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect SkinnyRx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on SkinnyRx's site. Not medical advice; see our disclosure.

← Back to the scorecard